Arkolith/Insider Trading/EFTR/Form 4

Ehrlich Christopher B

DirectoreFFECTOR Therapeutics, Inc. (EFTR) · full profile →Form 4 · filed Oct 6, 2022
Net Buying
Open-Market Buys
$197
Open-Market Sells
$0
Net Open-Market Flow
$197
Transactions
1
1 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Oct 4, 2022Buy(P)346$0.57$19735K

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001209191-22-052933) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML